# OLANZAPINE
> **ANDA219048** · Abbreviated New Drug Application (Generic) · Sponsor: OMNIVIUM PHARMS · Approved 2026-01-23
## Drug
- **FDA Application Number:** ANDA219048
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLANZAPINE
- **Generic name:** Olanzapine
- **Active ingredients:** OLANZAPINE
- **Dosage form:** POWDER
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** OMNIVIUM PHARMS
- **First approval:** 2026-01-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219048)
---
*AI Analytics · CC0 1.0*